Study: Smoking Linked to ALS Risk
A new study uncovers the dose-response relationship between smoking and risk of amyotrophic lateral sclerosis.
A new study uncovers the dose-response relationship between smoking and risk of amyotrophic lateral sclerosis.
Steve and Michel Gleason will receive ASHA's prestigious Annie Glenn Award at the ASHA Convention in New Orleans this November.
Quantum Rehab enters into a multiyear sponsorship of Team Gleason Foundation to ensure people living with ALS have power seat elevation.
EverythingALS announces NeuroSense Therapeutics Ltd as a new collaborator in the effort to identify treatments and a cure for ALS.
Read MoreNeuroSense and NeuraLight collaborate to advance the science of digital biomarkers in the detection and monitoring of ALS.
Read MoreNew Stage III biomarker data in people with ALS validates NeuroSense’s clinical strategy, the company reports.
Read MoreThe immune system may play a fundamental role along with the central nervous system in ALS, Mount Sinai researchers report.
Read MoreIn JAMA Neurology, researchers outline preliminary research that could pave the way for a future test for earlier diagnosis of ALS.
Read MoreResearchers have identified a relationship between the patterns of ALS symptoms and microscopic changes in the brain and spinal cord.
Read MoreStealth BioTherapeutics Corp presents SBT-272 preclinical data demonstrating improvement in upper neuron function in ALS.
Read MoreThe Muscular Dystrophy Association will honor Major League Baseball’s recognition of Lou Gehrig Day at games across the country in June.
Read MoreTeam Gleason and Synchron announce a partnership agreement to provide patient-focused feedback on their platform to transform daily life.
Read MoreSilence ALS initiative will offer an integrated solution to identify, support and potentially treat nano-rare ALS patients.
Read MoreProMIS Neurosciences Inc announces new milestones in potential therapeutic approaches for ALS, the company notes in a media release.
Read MoreTarget ALS announces Merit E. Cudkowicz as the winner of the first annual Target ALS Rebecca Luker Courage Award.
Read MoreMDA announces programming and events in support of people living with ALS throughout ALS Awareness Month in May.
Read MoreWeizmann Institute of Science researchers link a new gene to ALS that plays a defensive, rather than an offensive, role in the disease.
Read MoreJohns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities.
Read More